S5013

Salbutamol hemisulfate salt

≥98%

• Synonyme(s) : α-([t-Butylamino]methyl)-4-hydroxy-m-xylene-α,α′-diol, Albuterol
• Formule linéaire : C₁₃H₂₁NO₃ · 1/2H₂SO₄
• Numéro CAS: 51022-70-9
• Poids moléculaire : 288.35
• Numéro CE : 256-916-8
• Numéro MDL: MFCD00055200
• Code UNSPSC : 12352200
• ID de substance PubChem : 24277746
• Nomenclature NACRES : NA.77

Propriétés

• Essai: ≥98%
• Solubilité: 1 M NaOH: 50 mg/ml, clear to slightly hazy, yellow-green
• Auteur: GlaxoSmithKline
• Chaîne SMILES: OS(O)(=O)=O.CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.CC(C)(C)NCC(O)c2ccc(O)c(CO)c2
• InChI: 1S/2C13H21NO3.H2O4S/c2*1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;1-5(2,3)4/h2*4-6,12,14-17H,7-8H2,1-3H3;(H2,1,2,3,4)
• Clé InChI: BNPSSFBOAGDEEL-UHFFFAOYSA-N
• Informations sur le gène: human ... ADRB2(154)

Description

Application

Salbutamol hemisulfate salt has been used as reference standards of drugs for the validation of β-agonist residue.

Salbutamol hemisulfate salt was used as standard in analysis of fortified meat for LABA content using ELISA kits.³ It was used to study the response of prostaglandin 2α to various β-adrenergic agonists in cultured bovine endometrial cells.⁴

Actions biochimiques/physiologiques

β2-Adrenergic receptor agonist.

Salbutamol is a β2 adrenoceptor agonist with short acting bronchodilation and anti-inflammatory effects. It relaxes the airway smooth muscles and inhibits bronchoconstriction induced by adenosine-5′ -monophosphate (AMP). Salbutamol is particularly effective in treatment of asthma as it provides immediate relief. Salbutamol is one of the most popular short-acting BA (SABA). It is useful in treating the symptoms of EIB (exercise induced bronchospasm).

Salbutamol is a β2 adrenoceptor agonist with short acting bronchodilation and anti-inflammatory effects. It relaxes the airway smooth muscles and inhibits bronchoconstriction induced by adenosine-5′ -monophosphate (AMP).¹ Salbutamol is particularly effective in treatment of asthma as it provides immediate relief.²

Caractéristiques et avantages

This compound is featured on the β-Adrenoceptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Informations sur la sécurité

• Pictogrammes: GHS08,GHS07
• Mention d'avertissement: Warning
• Mentions de danger: H317,H351,H361fd
• Conseils de prudence: P202 - P261 - P272 - P280 - P302 + P352 - P308 + P313
• Classification des risques: Carc. 2 - Repr. 2 - Skin Sens. 1
• Code de la classe de stockage: 11 - Combustible Solids
• Classe de danger pour l'eau (WGK): WGK 2
• Point d'éclair (°F): Not applicable
• Point d'éclair (°C): Not applicable
• Équipement de protection individuelle: Eyeshields, Gloves, type N95 (US)